Titre
L'ablation endocavitaire: une nouvelle approache therapeutique des tachycardies supraventriculaires. [Endocavitary ablation: a new therapeutic approach to supraventricular tachycardia]
Type
synthèse (review)
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Schlapfer, J.
Auteure/Auteur
Goy, J. J.
Auteure/Auteur
Fromer, M.
Auteure/Auteur
Kappenberger, L.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
0036-7672
Statut éditorial
Publié
Date de publication
1992-03
Volume
122
Numéro
12
Première page
409
Dernière page/numéro d’article
15
Notes
English Abstract
Journal Article
Review --- Old month value: Mar 21
Journal Article
Review --- Old month value: Mar 21
Résumé
Nowadays patients suffering from supraventricular tachycardia are first treated with antiarrhythmic drugs. In refractory cases alternative treatment is antitachycardia pacemaker implantation or surgery. Recently new percutaneous catheter techniques have been developed to ablate directly the anatomical substrate responsible for the arrhythmia by delivering energy (high or low energy shock or radiofrequency) at the tip of a catheter. This article summarizes the results of clinical application of these different techniques and briefly presents our experience. The very recent studies with RF in patients with drug-refractory av nodal reentry or accessory pathway related tachycardia (WPW syndrome) report a success rate of 92-99% with a very low complication rate. If the long term success of radiofrequency is confirmed this technique will emerge in the near future as the treatment of choice in patients suffering from symptomatic supraventricular tachycardia, since it avoids expensive, longlasting drug treatment with the permanent risk of side effects.
Sujets
PID Serval
serval:BIB_AED4FF21764B
PMID
Date de création
2008-02-15T10:28:44.146Z
Date de création dans IRIS
2025-05-20T23:22:17Z